According to a new study, antipsychotic medications could increase the risk of death in patients with Parkinson's disease psychosis.
A new study reports people with Alzheimer's disease are more likely to use antipsychotic medications, and for longer periods of time, than the general public.
People with Alzheimer's disease who use antipsychotic medications have a 29% higher risk of head injury, and a 22% increased risk of TBI compared to those with the neurodegenerative disease who do not use the medications.
A new study reports many people with intellectual disabilities are being prescribed antipsychotic medications even though they have no record of mental illness.
A new study implicates serotonin 2c receptors with metabolic side effects caused by a common class of antipsychotic medications.
Alzheimer's patients who used antipsychotics had a 29% increased risk of head injury and a 22% higher risk of TBI compared to others with the neurodegenerative disease who did not use the medications.
Researchers report a blockade of D2 receptors in interneurons can increase acetylcholine signaling above threshold on neighboring neurons, resulting in motor abnormalities.
According to researchers, a mutation in a gene associated with brain development may dispose people to various psychiatric illnesses as it reduces synapse numbers. Lithium may help to restore some of the synapses.
While England has only seen a moderate rise in people being diagnosed with psychosis in recent years, prescription rates for antipsychotic medications have doubled.
Researchers provide possible new insights into psychiatric disorders such as schizophrenia.
Study reveals a moderate link between antipsychotic use and an increased risk of developing breast cancer.
Long-term antipsychotic use does not increase the risk of physical morbidity leading to hospitalization.
